Skip to main content
. Author manuscript; available in PMC: 2016 May 16.
Published in final edited form as: Am J Ophthalmol. 2007 Dec 11;145(2):257–266. doi: 10.1016/j.ajo.2007.09.025

FIGURE 2.

FIGURE 2

Patient 5, a 37-year-old Caucasian woman with CNV attributable to angioid streaks. Studies obtained at baseline and 2, 4, and 24 weeks after the first infusion are shown including BCVA in ETDRS letters read at 4 meters and Snellen equivalent, frames from early, mid, and late phases of FA, and horizontal and vertical cross-sections of OCT scans labeled T-N (temporal-nasal) and I-S (inferior-superior), respectively. At the primary endpoint of 24 weeks after the first infusion, the patient showed improved BCVA, reduced CNV lesion size, resolution of leakage, and resolution of subretinal and intraretinal fluid in the macula.